It might seem odd to describe a practice group at one of the country’s best-known firms as up-and-coming. The mass torts and insurance litigation group at Skadden, Arps, Slate, Meagher & Flom has done impressive work for years under the leadership of Sheila Birnbaum, a star of the product liability field. But two developments in 2009 significantly boosted the group’s profile.

The department’s first big break was when Pfizer Inc. picked partner Mark Cheffo as national coordinating counsel for litigation involving the antiepilepsy drug Neurontin. The pharma giant had previously used Davis Polk & Wardwell to handle consumer fraud suits related to Neurontin, and Shook, Hardy & Bacon to cover personal injury claims. But after Amy Schulman became Pfizer’s general counsel in 2008, the company selected Cheffo to coordinate both components of the Neurontin litigation.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]